Preclinical evaluation of a protracted GLP-1/glucagon receptor co-agonist: Translational difficulties and pitfalls.

MLA

Simonsen, Lotte, et al. “Preclinical Evaluation of a Protracted GLP-1/Glucagon Receptor Co-Agonist: Translational Difficulties and Pitfalls.” PloS One, vol. 17, no. 3, Mar. 2022, p. e0264974. EBSCOhost, https://doi.org/10.1371/journal.pone.0264974.

APA

Simonsen, L., Lau, J., Kruse, T., Guo, T., McGuire, J., Jeppesen, J. F., Niss, K., Sauerberg, P., Raun, K., & Dornonville de la Cour, C. (2022). Preclinical evaluation of a protracted GLP-1/glucagon receptor co-agonist: Translational difficulties and pitfalls. PloS One, 17(3), e0264974. https://doi.org/10.1371/journal.pone.0264974

Chicago

Simonsen, Lotte, Jesper Lau, Thomas Kruse, Tingqing Guo, Jim McGuire, Jacob Fuglsbjerg Jeppesen, Kristoffer Niss, Per Sauerberg, Kirsten Raun, and Charlotta Dornonville de la Cour. 2022. “Preclinical Evaluation of a Protracted GLP-1/Glucagon Receptor Co-Agonist: Translational Difficulties and Pitfalls.” PloS One 17 (3): e0264974. doi:10.1371/journal.pone.0264974.